PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA › SPbU Researchers Portal

PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Research output: Contribution to journal › Meeting Abstract › peer-review

Department of Mathematical Modelling of Energetic Systems

A. Kolbin
M. Frolov
A. Kurylev
Y. Balykina
M. Proskurin

Original language	English
Pages (from-to)	A442-A442
Number of pages	1
Journal	Value in Health
Volume	18
Issue number	7
State	Published - Nov 2015

ID: 9440446